Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988402 · ClinicalTrials.gov registry record · Phase 4
Does Allopurinol Prolong a Treated, Acute Gout Flare?
A Phase 4 study, sponsored by 59th Medical Wing.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT01988402 is a Phase 4 study that has completed, run by 59th Medical Wing. The registered enrollment target is 35 participants.
The verdict
NCT01988402, a Phase 4 study, has completed, sponsored by 59th Medical Wing.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.
Interventions
- DRUG allopurinol
- DRUG Placebo (sugar pill)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01988402
The ClinicalTrials.gov registry entry for NCT01988402 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which allopurinol is the first listed.
NCT01988402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01988402 about?
NCT01988402 is a clinical study titled "Does Allopurinol Prolong a Treated, Acute Gout Flare?". This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.
What is the current status of trial NCT01988402?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2007-12. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01988402?
The interventions under investigation include: allopurinol (DRUG), Placebo (sugar pill) (DRUG).
Who is sponsoring clinical trial NCT01988402?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.